Business Description

Cell MedX Corp logo
Cell MedX Corp
NAICS : 325413 SIC : 3845
ISIN : US15115X1072
Description
Cell MedX Corp is an early stage development company focused on the discovery, development and, commercialization of therapeutic products for patients with diseases such as diabetes, by developing technologies to help manage the illness and related complications. The company's product portfolio consists of electromedical technologies, ebalance, and others.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset -109.78
Debt-to-Equity -0.41
Debt-to-EBITDA -3.9
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 39.17
9-Day RSI 39.49
14-Day RSI 42.72
6-1 Month Momentum % -33.63
12-1 Month Momentum % 3.45

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.01
Quick Ratio 0.01
Cash Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4
Shareholder Yield % -4.58

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -6800
ROA % -741.15
ROIC % -28.28

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -30.51
EV-to-EBITDA -30.51
EV-to-Revenue 2694.67
EV-to-FCF -39.63
Earnings Yield (Greenblatt) % -3.28
FCF Yield % -2.88

Financials

CMXC's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CMXC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cell MedX Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.003
EPS (TTM) ($) -0.004
Beta 7371.15
Volatility % 500.27
14-Day RSI 42.72
14-Day ATR ($) 0.003704
20-Day SMA ($) 0.02684
12-1 Month Momentum % 3.45
52-Week Range ($) 0.0002 - 0.9312
Shares Outstanding (Mil) 294.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cell MedX Corp Filings

Filing Date Document Date Form
No Filing Data

Cell MedX Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cell MedX Corp Frequently Asked Questions

What is Cell MedX Corp(CMXC)'s stock price today?
The current price of CMXC is $0.02. The 52 week high of CMXC is $0.93 and 52 week low is $0.00.
When is next earnings date of Cell MedX Corp(CMXC)?
The next earnings date of Cell MedX Corp(CMXC) is .
Does Cell MedX Corp(CMXC) pay dividends? If so, how much?
Cell MedX Corp(CMXC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1